Table 1.
Cohort I (n = 84) | Cohort II (n = 14) | Cohort III (n = 5) | |
---|---|---|---|
Gender | |||
Male | 45 (53.6%) | 7 (50.0%) | 2 (40.0%) |
Female | 39 (46.4%) | 7 (50.0%) | 3 (60.0%) |
Median age (range) | |||
<65 | 63 (75.0%) | 6 (42.9%) | 1 (20.0%) |
≥65 | 21 (25.0%) | 8 (57.1%) | 4 (80.0%) |
T stage | |||
T1 | 5 (6.0%) | 0 (0.0%) | 0 (0.0%) |
T2 | 16 (19.0%) | 0 (0.0%) | 0 (0.0%) |
T3 | 49 (58.3%) | 9 (64.3%) | 2 (40.0%) |
T4 | 14 (16.7%) | 5 (35.7%) | 3 (60.0%) |
N stage | |||
N0 | 58 (69.0%) | 8 (57.1%) | 2 (40.0%) |
N+ | 26 (31.0%) | 6 (42.9%) | 3 (60.0%) |
M stage | |||
M0 | 70 (83.3%) | 12 (85.7%) | 5 (100.0%) |
M1 | 14 (16.7%) | 2 (14.3%) | 0 (0.0%) |
Stage | |||
I | 17 (20.2%) | 0 (0.0%) | 0 (0.0%) |
II | 35 (41.7%) | 7 (50.0%) | 2 (40.0%) |
III | 18 (21.4%) | 5 (35.7%) | 3 (60.0%) |
IV | 14 (16.7%) | 2 (14.3%) | 0 (0.0%) |
Location | |||
Colon | 36 (42.9%) | 9 (64.3%) | 5 (100.0%) |
Colon/Rectum | 48 (57.1%) | 5 (35.7%) | 0 (0.0%) |
Cohort 3 ⊆ Cohort 2 ⊆ Cohort 1.